Last week, families of children and young adults with Progeria welcomed the news that we are one step closer to the first approved treatment for this ultra-rare, devastating condition that causes ...

Biomedical engineers at Duke University constructed an advanced disease model for blood vessels prompting insights into Hutchinson-Gilford progeria syndrome, according to a study published in Stem ...

Progeria is an extremely rare genetic disease of childhood characterised by dramatic, premature ageing. The condition, which derives its name from “geras”, the Greek word for old age, is estimated to ...

Children with progeria age too quickly, developing symptoms common in much older people such as heart disease and joint stiffness. Treatments focus on managing symptoms, but the FDA could approve a ...

Gene therapy increased lifespan 25 percent in a mouse model of the fatal accelerated aging disease progeria, Salk Institute scientists reported Monday. Using the powerful CRISPR gene editing ...

In the spring of 2005, families affected by progeria welcomed the news from two studies that uncovered new information about this rare, devastating condition that causes premature aging in children.

The results of a University of Maryland (UMD)-led study could point to new and improved treatment approaches for Hutchinson-Gilford progeria syndrome (HGPS), a rare genetic disorder that causes ...

Research behind the therapy could lead to other discoveries about heart disease as well as the aging process. The FDA approved the first treatment to reduce the risk of mortality from progeria, an ...

Progeria is a very rare disease that affects about one in 18 million children and results in premature aging and death in adolescence from complications of cardiovascular disease. In a study on mice ...

Forbes contributors publish independent expert analyses and insights. I write about digital healthcare, biotech & innovation in medicine. A specialized gene editing technique that allows very small ...